PedAM
Pediatric Disease Annotations & Medicines
| Disease | spasticity |
| Phenotype | C0338596|spastic cerebral palsy |
| Sentences | 2 |
| PubMedID- 24235067 | Background: botulinum toxin a (btx-a) has been successfully used as a treatment for children with spastic cerebral palsy; however, the effect of btx-a on reducing spasticity only lasts a few months, thus serial injections are required. |
| PubMedID- 23967895 | To manage spasticity in children with spastic cerebral palsy botulinum toxin type-a (btx-a) injected by manual intramuscular needle placement in the lower extremity under general anaesthesia is an established treatment and standard of care in children with spastic cp [3-6]. |
Page: 1